Breast Cancer Awareness Month, observed every October worldwide, is a global health campaign recognised by the World Health Organization and leading cancer societies. Symbolised by the pink ribbon, ...
PriceMDs.com, Inc, an innovative healthcare technology and solutions company that significantly reduces medical costs for self-insured employers and their members, announced that it has entered into a ...
Au 30 juin 2025, la position de trésorerie d’OSE Immunotherapeutics s’élevait à 41,6 millions d’euros, contre 64,2 millions d’euros au 31 décembre 2024.
Nous prenons des décisions chaque jour, parfois sans même y penser. Devrions-nous prendre un café ? Traverser la rue ? Parier ...
This test is available exclusively through CNSide Diagnostics, LLC. as a testing service provided to health care professionals in the U.S.
(GLOBE NEWSWIRE) -- via IBN – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) (“Izotropic”, or the “Company”), a medical device company commercializing innovative, emerging technologies and ...
FDA and Capricor aligned on endpoints for HOPE-3 pivotal trial; HOPE-3 pivotal trial completed; topline data expected mid-Q4 2025 to support BLA resubmission; Company preparing to ...
In this initial two-site cycle, Kraig Labs successfully managed the logistics, material supply, and independent staffing requirements necessary to support parallel operations. Each facility operated ...
With this approval, NexoBrid is now authorized in 45 countries worldwide, reflecting its growing recognition as a new standard of care in burn management. MediWound’s exclusive partner in Australia, ...
CBSC’s exclusive Canadian distributor, Your Heart Protector Corp. (Calgary, Alberta), has placed an initial order for CardioHolter AT devices totaling $375,000 USD. Delivery of the first 1,000 devices ...
KIRKLAND, Wash., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today announced its debut at the 2025 ...
Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer's disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback